Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid.
Many drug compounds have limited solubility in water. To enhance the oral bioavailability of such compounds, pharmaceutical formulations target the creation of a supersaturated solution. Release of the compound from ordered mesoporous silica carrier is such a means for reaching supersaturation. Little is known about the evolution of supersaturated intestinal media. The present study reveals the phase transitions of the poorly water-soluble drug itraconazole in simulated intestinal fluid under conditions corresponding to supersaturation. Electron spin resonance of n-doxylstearic acid spin probes evidenced that during supersaturation itraconazole is solubilized inside the hydrophobic core of mixed micelles composed of lecithin and bile salt. Cryogenic transmission electron microscopy revealed that the supersaturated state of itraconazole provokes the formation of nanofibers with a uniform diameter of 12 nm. The nanofiber length determined via dynamic light scattering increases from 220 to 1480 nm after 30 and 90 min, respectively. Nanofibers drastically reduced transepithelial transport of itraconazole across a Caco-2 cell monolayer mimicking the gastrointestinal absorption. Based on our study, we suggest the existence of an optimum intraluminal itraconazole supersaturation at which itraconazole absorption is enhanced but formation of itraconazole nanofibers prevented.
Centre for Surface Chemistry and Catalysis, Laboratory for Pharmacotechnology and Biopharmacy, and Laboratory of Applied Rheology and Polymer Technology, K. U. Leuven, Belgium.
Randy
R
Mellaerts
Alexander
A
Aerts
Tom P
TP
Caremans
Jan
J
Vermant
Guy
G
Van den Mooter
Johan A
JA
Martens
Patrick
P
Augustijns
D000935:Antifungal Agents / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D018938:Caco-2 Cells / Q000378:metabolism; D006801:Humans; D007408:Intestinal Absorption; D017964:Itraconazole / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism*; D008823:Micelles; D046529:Microscopy, Electron, Transmission; D008962:Models, Theoretical; D057139:Nanofibers / Q000008:administration & dosage / Q000737:chemistry* / Q000648:ultrastructure; D012995:Solubility
D000935:Antifungal Agents; D008823:Micelles; D017964:Itraconazole